Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients.

导出 LinkOut

翻译打印收藏纠错

作者： Ben W,Mol ^[1] ; Patrick M,Bossuyt ^[2] ; Sesh K,Sunkara ^[3] ; Juan A,Garcia Velasco ^[4] ; Christos,Venetis ^[5] ; Denny,Sakkas ^[6] ; Kersti,Lundin ^[7] ; Carlos,Simón ^[8] ; Hugh S,Taylor ^[9] ; Robert,Wan ^[10] ; Salvatore,Longobardi ^[11] ; Evelyn,Cottell ^[11] ; Thomas,D'Hooghe ^[12]

作者单位： Monash University, Clayton, Victoria, Australia. ^[1] University of Amsterdam, Amsterdam, the Netherlands. ^[2] Queen's Hospital, Barking, Havering and Redbridge University Hospitals, Essex, United Kingdom. ^[3] IVI RMA Madrid and Rey Juan Carlos University, Madrid, Spain. ^[4] University of New South Wales, Sydney, New South Wales, Australia. ^[5] Boston IVF, Waltham, Massachusetts. ^[6] Sahlgrenska University Hospital, Goteborg, Sweden. ^[7] Igenomix, Valencia University, Valencia, Spain. ^[8] Yale University Medical School, New Haven, Connecticut. ^[9] EMD Serono, Billerica, Massachusetts. ^[10] Global Medical Affairs Fertility, Research and Development, Merck KGaA, Darmstadt, Germany. ^[11] Global Medical Affairs Fertility, Research and Development, Merck KGaA, Darmstadt, Germany; Research Group Reproductive Medicine, Department of Development and Regeneration, Organ Systems, Group Biomedical Sciences, KU Leuven (University of Leuven), Leuven, Belgium; Department of Obstetrics and Gynecology, Yale University, New Haven, Connecticut. Electronic address: thomas.dhooghe@merckgroup.com. ^[12]

关键词 ART Personalized medicine precision medicine trial design

主题词循证实践(Evidence-Based Practice);女(雌)性(Female);人类(Humans);排卵诱导(Ovulation Induction);生殖技术, 辅助(Reproductive Techniques, Assisted);研究设计(Research Design)

DOI 10.1016/j.fertnstert.2018.04.037

PMID 29935655

发布时间 2019-01-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交